ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 41 filers reported holding ENZO BIOCHEM INC in Q3 2023. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $2,000 | 0.0% | 329 | 0.0% | 0.00% | – |
Q3 2016 | $2,000 | 0.0% | 329 | 0.0% | 0.00% | – |
Q2 2016 | $2,000 | +100.0% | 329 | 0.0% | 0.00% | – |
Q1 2016 | $1,000 | 0.0% | 329 | 0.0% | 0.00% | – |
Q4 2015 | $1,000 | -99.9% | 329 | -99.9% | 0.00% | -100.0% |
Q3 2015 | $1,176,000 | -42.5% | 370,939 | -45.0% | 0.00% | -50.0% |
Q2 2015 | $2,044,000 | -3.9% | 674,751 | -6.4% | 0.00% | 0.0% |
Q1 2015 | $2,127,000 | -49.3% | 720,982 | -23.6% | 0.00% | -50.0% |
Q4 2014 | $4,192,000 | -23.2% | 944,043 | -10.9% | 0.00% | -33.3% |
Q3 2014 | $5,456,000 | -5.9% | 1,059,321 | -4.1% | 0.01% | -14.3% |
Q2 2014 | $5,800,000 | +21.8% | 1,104,843 | -3.5% | 0.01% | +16.7% |
Q1 2014 | $4,762,000 | +39.4% | 1,144,747 | -2.1% | 0.01% | +50.0% |
Q4 2013 | $3,415,000 | +12.5% | 1,169,562 | -2.9% | 0.00% | 0.0% |
Q3 2013 | $3,035,000 | +13.8% | 1,204,540 | -6.0% | 0.00% | 0.0% |
Q2 2013 | $2,667,000 | – | 1,282,042 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Evermore Global Advisors, LLC | 3,312,792 | $22,991,000 | 4.49% |
First Light Asset Management, LLC | 1,007,357 | $6,991,000 | 3.07% |
KOPP INVESTMENT ADVISORS LLC | 211,974 | $1,471,000 | 1.55% |
GLOBEFLEX CAPITAL L P | 223,931 | $1,554,000 | 0.39% |
Nine Chapters Capital Management LLC | 30,900 | $214,000 | 0.36% |
KEMPNER CAPITAL MANAGEMENT INC. | 70,001 | $486,000 | 0.35% |
Campbell & CO Investment Adviser LLC | 11,513 | $80,000 | 0.25% |
EAM Investors, LLC | 259,914 | $1,804,000 | 0.24% |
Teza Capital Management LLC | 14,636 | $102,000 | 0.14% |
Acrospire Investment Management LLC | 46,220 | $321,000 | 0.13% |